Vitamin E in Improving Treatment Outcomes in Diabetic Peripheral Neuropathy
Not Applicable
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2020/06/026142
- Lead Sponsor
- Dr Rudra Paul
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All consenting patients newly diagnosed with diabetes peripheral neuropathy
Exclusion Criteria
1. Pregnant and lactating females
2. Those unable to comprehend the purpose of the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Change in VAS score <br/ ><br>2. Change in mean Pain Score <br/ ><br>3. Change in BPI-DPN <br/ ><br>4. Patients Global Impression of ChangeTimepoint: Measured at <br/ ><br>baseline <br/ ><br>1 month <br/ ><br>3 month <br/ ><br>6 month
- Secondary Outcome Measures
Name Time Method 1. Medication Adherence Report Scale <br/ ><br>2. WHO-QoL BREF QuestionnaireTimepoint: Measured at <br/ ><br>baseline <br/ ><br>1 month <br/ ><br>3 month <br/ ><br>6 month